The Report Hepatitis C Pipeline Global Market for H1 2017 has been published at ReportsnReports providing reviews of pipeline therapeutics for Hepatitis C (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
Hepatitis C is a contagious viral infection affecting the liver. It may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. The characteristic symptoms include abdominal pain, fatigue, and fever, and jaundice, loss of appetite, nausea and vomiting. The predisposing factors of hepatitis C include dialysis, organ transplant and blood transfusion. Offspring of an infected mother also has high chances of contracting the disease. Hepatitis C can be controlled with the help of medications or a transplant at an advanced stage.
Avail the discount for the Hepatitis C Pipeline Report at http://www.reportsnreports.com/contacts/discount.aspx?name=983987 – This report is available at up to 25% Discount till June 02nd 2017.
Pharmaceutical and Healthcare latest pipeline guide Hepatitis C - Pipeline Review, provides comprehensive information on the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C - Pipeline Review, provides an overview of the Hepatitis C (Infectious Disease) pipeline landscape. The Key Company Profiles are 3-V Biosciences Inc, AbbVie Inc, AIMM Therapeutics BV, Akshaya Bio Inc, Amarillo Biosciences Inc, Amarna Therapeutics BV, ARA Healthcare Pvt Ltd, Aviragen Therapeutics Inc, Beijing Kawin Technology Share-Holding Co Ltd, Beta Pharma Inc, Biocad, Biotest Pharmaceuticals Corp, Biotron Ltd, Boehringer Ingelheim GmbH, Bolder Biotechnology Inc, Bristol-Myers Squibb Company, Cocrystal Pharma Inc, Conatus Pharmaceuticals Inc, ContraVir Pharmaceuticals Inc, DEKK-TEC Inc, Delpor Inc, F. Hoffmann-La Roche Ltd, Formune SL, Genecode AS, GeneCure LLC, Gilead Sciences Inc, GinkgoPharma Co Ltd, GlaxoSmithKline Plc, HanAll Biopharma Co Ltd, ImmunoBiology Ltd, ImmunoClin Corp, Immunotope Inc, Inovio Pharmaceuticals Inc, Integrated BioTherapeutics Inc, JN-International Medical Corp, Johnson & Johnson, Karyopharm Therapeutics Inc, Kineta Inc, Ligand Pharmaceuticals Inc, Medivir AB, Merck & Co Inc, Microbio Co Ltd, Microbiotix Inc, MultiCell Technologies Inc, NeuroVive Pharmaceutical AB, Novalex Therapeutics Inc, Novartis AG, NovaTarg Therapeutics Inc, Ono Pharmaceutical Co Ltd, Pfenex Inc, Pfizer Inc, PharmaEssentia Corp, Presidio Pharmaceuticals Inc, Profectus BioSciences Inc, Replicor Inc, Rodos BioTarget GmbH, Solon Eiendom ASA, SomaGenics Inc, Sorrento Therapeutics Inc, Sudershan Biotech Ltd, TaiGen Biotechnology Co Ltd, TaiwanJ Pharmaceuticals Co Ltd, Therapure Biopharma Inc, Theravectys SA, THEVAX Genetics Vaccine USA Inc, Vakzine Projekt Management GmbH, Vertex Pharmaceuticals Inc, WhanIn Pharmaceutical Co Ltd, Zylacta Corp,
The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 13, 23, 15, 1, 52, 45 and 4 respectively. Similarly, the Universities portfolio in Phase II, IND/CTA Filed, Preclinical and Discovery stages comprises 3, 1, 9 and 23 molecules, respectively.
Inquire for Hepatitis C Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=983987
Hepatitis C (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Hepatitis C (Infectious Disease).
The pipeline guide reviews pipeline therapeutics for Hepatitis C (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Hepatitis C (Infectious Disease) therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Hepatitis C (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Hepatitis C (Infectious Disease)
Purchase Hepatitis C research report Direct from http://www.reportsnreports.com/purchase.aspx?name=983987 .
Table of Contents:
Hepatitis C - Overview
Hepatitis C - Therapeutics Development
Hepatitis C - Therapeutics Assessment
Hepatitis C - Companies Involved in Therapeutics Development
Hepatitis C - Drug Profiles
Hepatitis C - Dormant Projects
Hepatitis C - Discontinued Products
Hepatitis C - Product Development Milestones

List of Tables.
Number of Products under Development for Hepatitis C
Hepatitis C Products under Development by Companies
Hepatitis C Products under Development by Universities/Institutes
Number of Hepatitis C Products by Stage and Target
Number of Hepatitis C Products by Stage and Mechanism of Action
Number of Hepatitis C Products by Stage and Route of Administration
Number of Hepatitis C Products by Stage and Molecule Type
Hepatitis C - Pipeline by Pfizer Inc
Hepatitis C - Pipeline by Biotron Ltd
Hepatitis C - Pipeline by Johnson & Johnson
Hepatitis C - Dormant Projects

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with your contact details.